首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan.
【24h】

Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan.

机译:来自日本的一项长期研究显示,产生广谱β-内酰胺酶的大肠杆菌和肺炎克雷伯菌的临床和分子流行病学。

获取原文
获取原文并翻译 | 示例
       

摘要

The detection rates of extended-spectrum beta-lactamase (ESBL)-producing bacteria in Japan are very low ( approximately 5%) compared with those obtained worldwide. Further, the current trend of these bacteria in Japan is not known, and few studies with longitudinal observations have been reported. To obtain epidemiologic data on ESBL-producing bacteria, their genotypic features, and their antibiotic resistance patterns in Japan, we analyzed bacterial isolates from hospitalized patients at our institution over the 7-year period from 2003 to 2009. Of 2,304 isolates, 202 (8.8%) were found to be ESBL producers, including Escherichia coli, Klebsiella pneumonia, and Proteus mirabilis. The detection rates of the ESBL-producing isolates gradually increased and reached 17.1% and 10.5% for the E. coli and K. pneumoniae strains, respectively, in 2009. Genotyping analysis showed that approximately 90% of the ESBL-producing isolates carried the CTX-M genotype, in which the CTX-M-9 group was predominant, although the CTX-M-2 group is considered to be the main genotype in Japan; further, many of the strains produced multiple beta-lactamases. The detection rates of ESBL-producing bacteria may tend to be high within a limited region in Japan. A countrywide survey is required to understand the trend for ESBL-producing bacteria at the national level. In addition, our findings suggest that the genotypes of the detected ESBL producers are similar to those exhibiting a successful nosocomial spread worldwide.
机译:与全球范围内获得的结果相比,日本生产广谱β-内酰胺酶(ESBL)的细菌的检测率非常低(约5%)。此外,日本尚不清楚这些细菌的当前趋势,并且很少有关于纵向观察的研究报道。为了获得日本产ESBL细菌,其基因型特征和抗生素耐药性模式的流行病学数据,我们分析了我院2003年至2009年这7年期间住院患者的细菌分离株。在2,304株分离株中,有202(8.8)被发现是ESBL的生产者,包括大肠杆菌,肺炎克雷伯菌和奇异变形杆菌。产ESBL分离株的检出率逐渐提高,2009年大肠杆菌和肺炎克雷伯菌菌株的检出率分别达到17.1%和10.5%。基因分型分析表明,约90%的ESBL分离株带有CTX。 -M基因型,其中CTX-M-9组占主导地位,尽管CTX-M-2组被认为是日本的主要基因型;此外,许多菌株产生多种β-内酰胺酶。在日本的有限区域内,产生ESBL的细菌的检出率可能会很高。需要在全国范围内进行调查,以了解在国家一级产生ESBL的细菌的趋势。此外,我们的发现表明,检测到的ESBL生产者的基因型与在全球范围内成功传播医院的基因型相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号